Are the "Cardiac Benefits" of Empagliflozin Independent of Its Hypoglycemic Activity? (ATRU-4).

Name: Are the "Cardiac Benefits" of Empagliflozin Independent of Its Hypoglycemic Activity? (ATRU-4).
License: Public Domain

Icahn School of Medicine at Mount Sinai

ClinicalTrials.gov · Datasets · License: Public Domain

cardiovascular diseases

This document is indexed with metadata only — full text is not available in the archive for this record. Open the official source ↗

Record · ID 300410
Retrieved via Conceptio — every document is proof-bundled with source, license, and retrieval metadata.